Variant report
Variant | nsv613348 |
---|---|
Chromosome Location | chr9:9816955-9851382 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs80152062 | chr9:9820066-9820067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs149319750 | chr9:9820110-9820111 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs563910776 | chr9:9820165-9820166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs75971064 | chr9:9820169-9820170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs549725693 | chr9:9820177-9820178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs568031857 | chr9:9820194-9820195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs533850825 | chr9:9820196-9820197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs547440821 | chr9:9820202-9820203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs143624813 | chr9:9820241-9820242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs576123458 | chr9:9820272-9820273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs190236499 | chr9:9820273-9820274 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs549562963 | chr9:9820277-9820278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs569543277 | chr9:9820278-9820279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs555364992 | chr9:9820318-9820319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs535349353 | chr9:9820372-9820373 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs12552705 | chr9:9820375-9820376 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs571965584 | chr9:9820391-9820392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs2761758 | chr9:9820401-9820402 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs10739200 | chr9:9820412-9820413 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs76001700 | chr9:9820445-9820446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs558188470 | chr9:9820467-9820468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs371202995 | chr9:9820474-9820475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs148033448 | chr9:9820488-9820489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs182476654 | chr9:9820492-9820493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs532957302 | chr9:9820498-9820499 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs185663678 | chr9:9820504-9820505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs556261939 | chr9:9820509-9820510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs574317568 | chr9:9820541-9820542 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs189389596 | chr9:9820570-9820571 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs559816154 | chr9:9820616-9820617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs113276522 | chr9:9820623-9820624 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs547069791 | chr9:9820632-9820633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs181016538 | chr9:9820635-9820636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs116367673 | chr9:9820703-9820704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs543630553 | chr9:9820736-9820737 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs185695676 | chr9:9820763-9820764 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs188693195 | chr9:9820773-9820774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs12336546 | chr9:9820811-9820812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs181469842 | chr9:9820817-9820818 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs562806262 | chr9:9820885-9820886 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs186167608 | chr9:9820952-9820953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs574429391 | chr9:9820985-9820986 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs536173398 | chr9:9820995-9820996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs547124632 | chr9:9825231-9825232 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs181626261 | chr9:9825244-9825245 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs539253109 | chr9:9825306-9825307 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs549624611 | chr9:9825307-9825308 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs569843813 | chr9:9825314-9825315 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs10816191 | chr9:9825326-9825327 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs35778702 | chr9:9825339-9825340 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 20668451 | CNVD |
Schizophrenia | 20838587 | CNVD |
Glioblastoma | 18772890 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Lung adenocarcinoma | 17982442 | CNVD |
Breast cancer | 21611746 | CNVD |
Schizophrenia | 23813976 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:9820000-9821000 | Enhancers | NH-A | brain |
2 | chr9:9825200-9825400 | Active TSS | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr9:9825400-9825600 | Bivalent/Poised TSS | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr9:9832800-9834600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr9:9834200-9834600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
6 | chr9:9845200-9845800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
7 | chr9:9845400-9846200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr9:9845400-9846200 | Enhancers | Dnd41 | blood |
9 | chr9:9845800-9846800 | Enhancers | Primary hematopoietic stem cells | blood |
10 | chr9:9845800-9847000 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
11 | chr9:9845800-9847800 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
12 | chr9:9846200-9847000 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
13 | chr9:9846200-9847000 | Flanking Active TSS | Dnd41 | blood |
14 | chr9:9846600-9847000 | Active TSS | GM12878-XiMat | blood |
15 | chr9:9846800-9847200 | Weak transcription | Primary hematopoietic stem cells | blood |
16 | chr9:9847000-9848200 | Enhancers | Dnd41 | blood |
17 | chr9:9847000-9848400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
18 | chr9:9847000-9848600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
19 | chr9:9847200-9848400 | Enhancers | Primary hematopoietic stem cells | blood |
20 | chr9:9847600-9847800 | Enhancers | GM12878-XiMat | blood |
21 | chr9:9847600-9848200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
22 | chr9:9847600-9848200 | Enhancers | Placenta | Placenta |
23 | chr9:9848200-9855000 | Weak transcription | Placenta | Placenta |
24 | chr9:9848600-9855400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |